ARTUSI, CARLO ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 1.687
AS - Asia 1.063
EU - Europa 885
SA - Sud America 132
AF - Africa 65
OC - Oceania 5
Totale 3.837
Nazione #
US - Stati Uniti d'America 1.646
SG - Singapore 491
RU - Federazione Russa 396
IT - Italia 255
CN - Cina 167
VN - Vietnam 156
HK - Hong Kong 103
BR - Brasile 94
GB - Regno Unito 52
DE - Germania 37
FR - Francia 32
BD - Bangladesh 23
FI - Finlandia 23
NL - Olanda 18
CA - Canada 17
IN - India 17
ID - Indonesia 16
KR - Corea 15
MX - Messico 15
IQ - Iraq 14
ZA - Sudafrica 13
NG - Nigeria 12
BJ - Benin 11
ES - Italia 10
AR - Argentina 9
AT - Austria 9
IE - Irlanda 9
PK - Pakistan 9
SE - Svezia 9
JP - Giappone 8
SA - Arabia Saudita 8
TG - Togo 8
TR - Turchia 8
EC - Ecuador 7
PL - Polonia 7
VE - Venezuela 7
PH - Filippine 6
UA - Ucraina 6
AU - Australia 5
CH - Svizzera 5
DZ - Algeria 5
MY - Malesia 5
CO - Colombia 4
MA - Marocco 4
PE - Perù 4
CL - Cile 3
EG - Egitto 3
SV - El Salvador 3
BE - Belgio 2
CZ - Repubblica Ceca 2
GE - Georgia 2
HN - Honduras 2
JO - Giordania 2
KE - Kenya 2
LT - Lituania 2
NP - Nepal 2
OM - Oman 2
PY - Paraguay 2
RO - Romania 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
LY - Libia 1
MD - Moldavia 1
NA - Namibia 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SL - Sierra Leone 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 3.837
Città #
Dallas 630
San Jose 499
Singapore 321
Verona 183
Moscow 146
Council Bluffs 135
Ashburn 123
Hong Kong 102
Ho Chi Minh City 55
Hanoi 40
New York 26
Beijing 22
The Dalles 18
Milan 16
Buffalo 15
Los Angeles 15
Chandler 13
London 13
São Paulo 12
Bologna 11
Cotonou 11
Abuja 10
Helsinki 10
Lappeenranta 10
Amsterdam 9
Haiphong 9
Jakarta 9
Da Nang 8
Dublin 8
Lomé 8
Redondo Beach 8
Nuremberg 7
Phoenix 7
Southend 7
Tokyo 7
Baghdad 6
Munich 6
Biên Hòa 5
Cape Town 5
Caracas 5
Chicago 5
Des Moines 5
Geneva 5
Montreal 5
Redmond 5
Santa Clara 5
Toronto 5
Vienna 5
Brooklyn 4
Falkenstein 4
Jacksonville 4
Madrid 4
Manchester 4
Mexico City 4
Poplar 4
Riyadh 4
Stockholm 4
Warsaw 4
Algiers 3
Atlanta 3
Belo Horizonte 3
City of London 3
Dhaka 3
Glasgow 3
Guangzhou 3
Islamabad 3
Jeddah 3
Kuala Lumpur 3
Kyiv 3
Lawrence 3
Marseille 3
Princeton 3
Rio de Janeiro 3
San Salvador 3
Santo André 3
Sydney 3
Turku 3
Ankara 2
Asunción 2
Birmingham 2
Bordeaux 2
Boydton 2
Brasília 2
Cairo 2
Can Tho 2
Catania 2
Changsha 2
Columbus 2
Cuenca 2
Dong Ket 2
Erbil 2
Frankfurt am Main 2
Hebei 2
High Point 2
Hải Dương 2
Istanbul 2
Johannesburg 2
Juiz de Fora 2
Lagos 2
Lahore 2
Totale 2.733
Nome #
The Influence of Genetics in the Early Development of Axial Postural Abnormalities in Parkinson's Disease 344
The Complex Pathway of Conventional Investigations before the Diagnosis of Functional Motor Disorders 334
Camera- and Viewpoint-Agnostic Evaluation of Axial Postural Abnormalities in People with Parkinson’s Disease through Augmented Human Pose Estimation 128
Assessment of axial postural abnormalities in Parkinsonism: automatic picture analysis software 126
Axial postural abnormalities in Parkinsonism: gaps in predictors, pathophysiology, and management 118
Advances in diagnosis, classification, and management of pain in Parkinson's disease 112
Postural abnormalities in Parkinson's Disease: an epidemiological and clinical multicenter study 102
Does the degree of trunk bending predict patient disability, motor impairment, falls, and back pain in Parkinson's Disease? 102
Dynamic Video Assessment of Axial Postural Abnormalities in Parkinson's Disease: A Pilot Study 99
Botulinum toxin for axial postural abnormalities in Parkinson's Disease: a systematic review 99
Task force consensus on nosology and cut-off values for axial postural abnormalities in parkinsonism 94
Predictors and pathophysiology of axial postural abnormalities in Parkinsonism: a scoping review 93
Freezing of gait detection: The effect of sensor type, position, activities, datasets, and machine learning model 93
Validity of the wall goniometer as a screening tool to detect postural abnormalities in Parkinson's disease 93
Longitudinal assessment of Botulinum Toxin treatment for lateral trunk flexion and Pisa Syndrome in Parkinson's Disease: real-life, long-term study 84
Visuospatial Deficits Are Associated with Pisa Syndrome and not Camptocormia in Parkinson's Disease 74
Reply: "Human Pose Estimation Is Approximate: Limitations and Considerations for its Use in Clinical Trials" 72
Treatment of axial postural abnormalities in parkinsonism disorders: A systematic review of pharmacological, rehabilitative and surgical interventions 68
Filling the gap in assessing pain in dystonia 66
Clinical Algorithm-Guided Approach to Botulinum Toxin Type A Treatment for Axial Postural Abnormalities in Parkinson's Disease 48
Placebo Responses in Trials of Functional Neurologic Disorders 38
A multi-level annotated sensor dataset of gait freezing manifestations and severity in Parkinson's disease 38
Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation 35
Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a GBA1 Pathogenic Variant 25
Is segmental/multifocal onset a distinct presentation of idiopathic adult-onset dystonia? 25
Does sex influence the natural history of idiopathic adult-onset dystonia? 24
From RGB-D to RGB-Only: Reliability and Clinical Relevance of Markerless Skeletal Tracking for Postural Assessment in Parkinson’s Disease 21
Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations 21
Nonmotor fluctuations in Parkinson's disease: impact on caregiving and quality of life 20
NoMoFa as a new tool to evaluate the impact of deep brain stimulation on non-motor fluctuations: A new perspective 19
Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson?s disease patients 19
Burden of caregiving for cardiovascular dysautonomia in Parkinson?s disease 19
Long-term motor and cognitive outcome of Deep Brain Stimulation in GBA-PD: the Italian PARKNET study 19
Digital work engagement among Italian neurologists 19
Speech Impairment in Parkinson's Disease: Acoustic Analysis of Unvoiced Consonants in Italian Native Speakers 19
A new index to assess turning quality and postural stability in patients with Parkinson{'}s disease 18
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials 18
Multidisciplinary care use in neurodegenerative complex diseases: The example of progressive supranuclear palsy and advanced Parkinson's disease in real-life 18
Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab 17
Effect of deep brain stimulation frequency on gait symmetry, smoothness and variability using IMU 17
Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum 17
Botulinum toxin for Pisa syndrome: An MRI-, ultrasound- and electromyography-guided pilot study 17
Editorial: Digital biomarkers in movement disorders 17
Gait and axial postural abnormalities correlations in Parkinson{'}s disease: A multicenter quantitative study 17
Unraveling the stride: exploring the influence of neurogenic orthostatic hypotension on gait and balance in Parkinson?s disease 17
15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson?s disease patient with Parkin gene mutation: a case report 16
Smartphone-Based Evaluation of Postural Stability in Parkinson’s Disease Patients During Quiet Stance 16
Expanded and independent validation of the NoMoFA scale for Parkinson?s disease: the Italian version 16
Low frequency subthalamic stimulation and event-related potentials in Parkinson disease 16
Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson?s disease 16
Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild {COVID}-19 infection 15
Should we offer deep brain stimulation to Parkinson?s disease patients with GBA mutations? 15
The impact of dysphagia in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel 15
The still under-investigated role of cognitive deficits in PML diagnosis 15
Subthalamic deep brain stimulation and trunk posture in Parkinson's disease 15
Earlier versus later subthalamic deep brain stimulation in Parkinson's disease 15
Postural abnormalities in Asian and Caucasian Parkinson{\textquotesingle}s disease patients: A multicenter study 15
Biomechanical assessment of botulinum toxin effects in Pisa syndrome disease 15
Parkinsonism-hyperpyrexia syndrome due to gastroparesis treated with subcutaneous foslevodopa: a case report 15
Levodopa-Induced Neuropathy: A Systematic Review 15
Ventral tegmental area disconnection contributes two years early to correctly classify patients converted to alzheimer's disease: Implications for treatment 14
Clinical MRI to predict motor and non-motor effects of deep brain stimulation in Parkinson disease 14
Orthostatic hypotension in Parkinson disease: Impact on health care utilization 14
Pregnancy, fertile life factors, and associated clinical course in PRKN early-onset Parkinson?s disease 14
Tuning deep brain stimulation related depression by frequency modulation: A case report 14
Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-up 14
Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort 14
Detection of Freezing of Gait in People with Parkinson{'}s Disease using Smartphones 14
Subthalamic deep brain stimulation and levodopa in Parkinson?s disease: a meta-analysis of combined effects 14
Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors 14
Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson{'}s disease 14
80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: Effects on involuntary movements 14
Pisa syndrome in Parkinson's disease is associated with specific cognitive alterations 14
The relationship between occupation and specific forms of idiopathic adult-onset dystonia 14
Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis 13
Subthalamic and Nigral Stimulation for Freezing of Gait in Parkinson disease: randomized pilot trial 13
Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: A role for age at disease onset? 13
(Re)configuration of digital health records to optimize diagnosis and therapy 13
Identifying Poor Responders to STN DBS in Parkinson Disease: The Role of Rapid Disease Progression in the First Year in Optimal Responders to Levodopa 13
Parkinson{'}s disease progression at 30 years: A study of subthalamic deep brain-stimulated patients 13
Motor and non-motor outcomes of subthalamic deep brain stimulation in a case of juvenile PARK-PINK1 13
Early Detection of Dysphagia Signs in Parkinson’s Disease: An Artificial Intelligence-Based Approach Using Non-Invasive Sensors 13
Medical therapy and subthalamic deep brain stimulation in advanced Parkinson{'}s disease: A different long-term outcome? 13
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: A 7-year experience 13
Incidence and predictors of postural abnormalities in Parkinson?s disease: a PPMI cohort study 13
G325R GBA mutation in Parkinson's disease: Disease course and long- term DBS outcome 13
Axial symptoms as main predictors of short-term subthalamic stimulation outcome in Parkinson{'}s disease 13
Deep brain stimulation fine-tuning in Parkinson's disease: Short pulse width effect on speech 12
Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases 12
CACNA1A variant associated with generalized dystonia 12
Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report 12
Ultrasound-guided botulinum toxin-a injections: A method of treating sialorrhea 12
Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease 12
Prevalence and burden of dysautonomia in advanced Parkinson's disease 12
Predictors of cognitive performance in idiopathic adult-onset dystonia 12
Changing the Side of Pisa Syndrome: A Case of Over‐Recovery with Botulinum Toxin 12
Behind the scenes: exploring neurological journal editors{'} work habits, decisions, and potential sources of conflict of interest 12
Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study 12
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic 12
Levodopa-Induced Dyskinesias and Dyskinesias-Reduced-Self-Awareness in Parkinson’s Disease: A Neurocognitive Approach 12
Totale 3.634
Categoria #
all - tutte 10.730
article - articoli 10.634
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 96
Totale 21.460


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 2 4
2021/202213 0 3 0 0 0 0 0 2 0 1 2 5
2022/202351 3 8 4 5 4 10 1 2 3 4 4 3
2023/202478 5 3 6 9 8 21 8 2 0 4 6 6
2024/2025306 16 11 16 42 15 6 15 23 41 24 30 67
2025/20263.548 70 63 644 180 426 110 151 1.015 520 369 0 0
Totale 4.041